All In Biotech

Drug Trial Radar · NCT07570862

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe Systemic Lupus Erythematosus With Lupus Nephritis (RECLAIM-LN)

Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

53

Planned (sponsor's estimate)

Start

Jul 27, 2026

Primary completion

Jul 1, 2029

Study completion Jan 31, 2030

Sponsor

Lead sponsor
Fate TherapeuticsIndustry
Sponsor type
Industry
First posted
May 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following bendamustine administration in participants with refractory moderate-to-severe lupus nephritis, as assessed by the proportion of participants who achieve complete renal response (CRR) at Week 26.

Conditions

  • Lupus Nephritis
  • Systemic Lupus Erythematosus
  • SLE - Systemic Lupus Erythematosus
  • Lupus Nephritis - WHO Class III
  • Lupus Nephritis - WHO Class IV

Interventions

  • FT819Biological

    Single Intravenous (IV) infusion of FT819 administered on Day 1

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Renal Response (CRR) at Week 26Time frame: Week 26

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Wallace Rheumatic Studies Center

    Beverly Hills, California · Recruiting

  • Kaiser Permanente Fontana

    Fontana, California · Recruiting

  • Providence Medical Foundation

    Fullerton, California · Recruiting

  • University of California Irvine

    Irvine, California · Recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • GNP Research

    Cooper City, Florida · Recruiting

  • University of Florida Clinical Research Center

    Gainesville, Florida · Recruiting

  • Miami Dermatology and Laser Research

    Miami, Florida · Recruiting

  • Nicklaus Children's Hospital

    Miami, Florida · Recruiting

  • University of Nebraska Medical Center

    Omaha, Nebraska · Recruiting

  • Cross Creek Medical Clinic

    Fayetteville, North Carolina · Recruiting

  • The University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.